JagannadhaRAvasaralaMDPhD

PubMed

• Metronomic radiological surveillance in clinically stable MS patients on anti CD20 immunotherapy is redundant.
  Jagannadha Avasarala> ;Multiple Sclerosis and Related Disorders. 2024 Mar 6
• Inclusion of race-neutral data as fundamental to preventing misguided AI modeling.
  Avasarala, J., Das, S.> ;Computers in Biology and Medicine. 2024 Jan 1
• Unmasking disparities: the challenge of diversity, equity, and inclusion in Press Ganey surveys.
  Jagannadha Avasarala, Phenu Zachariah> ;CNS Spectrums. 2024 Apr 1
• Antibody panels for autoimmune and paraneoplastic disorders: A pandora's box for clinicians.
  Jagannadha Avasarala, Saurav Das, Sally Mathias, Sharoon Qaiser> ;Multiple Sclerosis and Related Disorders. 2022 Aug 1
• 4 citations
  VAERS-reported new-onset seizures following use of COVID-19 vaccinations as compared to influenza vaccinations.
  Jagannadha Avasarala, Christopher J McLouth, Luther C Pettigrew, Sally Mathias, Sharoon Qaiser, Phenu Zachariah> ;British Journal of Clinical Pharmacology. 2022 Nov 1
• Dosing schedules for Ofatumumab in multiple sclerosis: Overegging the pudding.
  Jagannadha Avasarala, Patricia A Olson> ;Multiple Sclerosis and Related Disorders. 2021 Sep 4
• 2 citations
  Radiologically isolated syndrome is antiquated amidst evolving McDonald criteria for multiple sclerosis.
  Jagannadha Avasarala, Fawad Yousuf> ;CNS Spectrums. 2021 Aug 1
• 7 citations
  Eculizumab package insert recommendations for meningococcal vaccinations: call for clarity and a targeted approach for use of the drug in neuromyelitis optica spectrum...
  Jagannadha Avasarala, Brent S. Sokola, Selina Mullins> ;CNS Spectrums. 2021 Jun 1
• 7 citations
  Use of anti-TNF-α therapy in Crohn's disease is associated with increased incidence of multiple sclerosis.
  Jagannadha Avasarala, Zain Guduru, Christopher J. McLouth, Amanda Wilburn, J. Talbert, Paige Sutton, Brent S. Sokola> ;Multiple Sclerosis and Related Disorders. 2021 Apr 9
• 1 citations
  Pivotal clinical trial enrollment of Blacks in multiple sclerosis or neuromyelitis spectrum disorder: when will we achieve parity?
  Jagannadha Avasarala, Phenu Zachariah, Breck Turner> ;CNS Spectrums. 2021 Feb 10
• Discordant disability data in multiple sclerosis phase 3 studies among sphingosine-1- receptor modulator drugs.
  Jagannadha Avasarala> ;Multiple Sclerosis and Related Disorders. 2020 Sep 28
• 5 citations
  Anti-MOG and Anti-AQP4 positive neuromyelitis optica spectrum disorder in a patient with myasthenia gravis.
  Molly Bates, Jason Chisholm, Eric Miller, Jagannadha Avasarala, Zain Guduru> ;Multiple Sclerosis and Related Disorders. 2020 Sep 1
• Clinical suspicion: Improving the odds of survival in rapidly progressive brainstem PRES in neuromyelitis optica spectrum disorder.
  Jagannadha Avasarala, Paige Sutton> ;Multiple Sclerosis and Related Disorders. 2020 Jul 3
• 2 citations
  Can a diagnosis of multiple sclerosis be made without ruling out neuromyelitis optica spectrum disorder
  Jagannadha Avasarala, Creed Pettigrew, Paige Sutton, Zain Guduru, Julie A. Gurwell, Brent S. Sokola, Selina Mullins> ;Multiple Sclerosis and Related Disorders. 2020 May 1
• Reader response: Optical coherence tomography for diagnosing optic neuritis: Are we there yet?
  Jagannadha Avasarala> ;Neurology. 2020 Jan 7
• 6 citations
  FDA-approved drugs for multiple sclerosis have no efficacy or disability data in non-Caucasian patients.
  Jagannadha Avasarala> ;CNS Spectrums. 2019 Jan 3
• Reader response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.
  Jagannadha Avasarala> ;Neurology. 2018 Sep 18
• 3 citations
  Can Aspirin Minimize Stroke Risk and New Lesion Formation in Multiple Sclerosis
  Jagannadha Avasarala, Naveen Parti> ;Frontiers in Neurology. 2018 Aug 8
• Reader Response: Practice Current: How do you treat neuromyelitis optica?
  Jagannadha Avasarala> ;Neurology. Clinical Practice. 2018 Aug 1
• 3 citations
  Reader response: Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.
  Jagannadha Avasarala> ;Neurology. 2018 Jul 3
• 8 citations
  DRESS Syndrome and Daclizumab Failure-Were Potentially Dangerous Signs Missed in Clinical Trials?
  Jagannadha Avasarala> ;Drug Target Insights. 2018 Jun 29
• 9 citations
  Forkhead box C1 gene variant causing glaucoma and small vessel angiopathy can mimic multiple sclerosis
  Jagannadha Avasarala, Julie R. Jones, Curtis R. Rogers> ;Multiple Sclerosis and Related Disorders. 2018 Apr 21
• 9 citations
  Anti-CD20 Cell Therapies in Multiple Sclerosis-A Fixed Dosing Schedule for Ocrelizumab is Overkill.
  Jagannadha Avasarala> ;Drug Target Insights. 2017 Oct 25
• 1 citations
  Leptomeningeal Enhancement for Multiple Sclerosis: Another Radiological Biomarker for a Relapse?
  Jagannadha Avasarala> ;JAMA Neurology. 2017 Jun 1
• 6 citations
  Approach to Fingolimod-Induced Lymphopenia in Multiple Sclerosis Patients: Do We Have a Roadmap?
  Jagannadha Avasarala, Sandip Jain, Enrique Urrea-Mendoza> ;Journal of Clinical Pharmacology. 2017 May 25
• Join now to see all

Journal Articles

• Clinically Isolated Syndrome - Rethinking the diagnosis  
  Jagannadha Avasarala, Journal of the Neurological Sciences
• Clinically Isolated Syndrome - Rethinking the diagnosis  
  Jagannadha Avasarala, Journal of the Neurological Sciences
• Differential microarray gene analyses of brain lesions in African-American and Caucasians with multiple sclerosis – correlation with microRNA profiling arrays  
  Avasarala JR, Chittur S, Internet J of Neurology, 1/1/2009
• Combined gene and transcriptional network analysis of immortalized B lymphocytes in siblings with/without multiple sclerosis – role for tcf2  
  Avasarala JR, Chittur S, George A, Tine J, BMC Medical Genomics, 1/1/2008
• Analysis of NAMCS data for multiple sclerosis, 1998–2004  
  Avasarala JR, O'Donovan C, Roach ES, Camacho F and Feldman SR, BMC Medicine, 1/1/2007
• Ventricular obstruction from neurocysticercosis  
  Gordon E, Cartwright M, Avasarala JR, Archives of Neurology, 6/1/2005
• Recombinant Erythropoietin Downregulates Specific TNF-Mediated Gene Ontology Pathways in Primary Cultures of Human MVECs: Implications for Multiple Sclerosis  
  Avasarala JR and Sastry K, Journal of Molecular Neuroscience, 1/1/2005
• A distinctive molecular signature of multiple sclerosis derived from MALDI-TOF/MS and serum proteomic pattern analysis: detection of three biomarkers  
  Avasarala JR, et al, Journal of Molecular Neuroscience, 1/1/2005
• Book Review: Neurological Disorders - Course and Treatment, 2nd Edition, Academic Press  
  Avasarala JR, Archives of Neurology, 1/1/2004
• A preliminary approach to the use of proteomics in the identification of proteins associated with multiple sclerosis during pregnancy  
  Avasarala JR, et al, Applied Genomics and Proteomics, 1/1/2003
• Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis  
  Avasarala JR, et al, Multiple Sclerosis, 1/1/2003
• Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis  
  Avasarala JR, et al, Multiple Sclerosis, 1/1/2003
• Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department  
  Pesola GR, Avasarala JR., Journal of Emergency Medicine, 1/1/2002
• Oligoclonal band number as a marker for prognosis in multiple sclerosis  
  Avasarala JR et al, Arch Neurology, 1/1/2001
• Surrogate markers in multiple sclerosis  
  Avasarala JR, Archives of Neurology, 1/1/2001
• Blood pressure reduction and stroke  
  Pesola GR, Avasarala JR et al, Journal of Emergency Medicine, 1/1/2001
• Distribution of peptidases in cultured cells from middle ear mucosa: prolyl endopeptidase is localized in fibroblasts and dipeptidyl peptidase IV and II in epithelial ...  
  Avasarala JR et al, Biochemical Medicine and Metabolic Biology, 1/1/1991
• Presence of dipeptidyl peptidase II, IV and prolyl endopeptidase in effusion from patients with serous otitis media  
  Avasarala JR et al, Biochemical Medicine and Metabolic Biology, 1/1/1991
• Analysis of airflow sounds in patent vs occluded tracheostomy tubes: a pilot study in tracheostomized adult patients  
  Avasarala JR et al, Laryngoscope, 1/1/1990
• Model of a new generation of tracheostomy and endotracheal tubes  
  Avasarala JR et al, Annals of Otology, Rhinology & Laryngology, 1/1/1989
• Metastatic gallbladder carcinoma of the palatine tonsil  
  Asami K, Yokoi T, Hattori T, Avasarala JR, Yanagita N, Journal of Laryngology and Otology, 1/1/1989
• Food for thought - Are tracheostomy tubes redundant?  
  Avasarala JR, Arch Otol Laryngol, 1/1/1989
• Use of pulse oximetry for monitoring tracheostomy tube obstruction  
  Avasarala JR et al, Otolaryngology, 1/1/1988
• Laryngeal pacemaker  
  Avasarala JR, Laryngoscope, 1/1/1988
• Benign fibrous histiocytoma of the temporal bone  
  Avasarala JR, Indian Journal of Otolaryngology, 1/1/1986
• Join now to see all

Abstracts/Posters

• A blood test to diagnose multiple sclerosis using MALDI-TOF/MS and serum proteomic pattern analysis: discovery of 3 biomarkers
  Avasarala JR, 56th Annual meeting of the American Academy of Neurology, San Francisco, CA, 4/1/2004
• Recombinant Erythropoietin Downregulates Specific TNF-Mediated Gene Ontology Pathways in Primary Cultures of Human MVECs: Implications for Multiple Sclerosis
  Avasarala JR, 56th Annual meeting of the American Academy of Neurology, San Francisco, CA, 4/1/2004
• Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis
  Avasarala JR et al, Proceedings of the VIII Annual ACTRIMS meeting, Baltimore, 10/19/2003
• Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis
  Avasarala JR et al, Proceedings of the VIII Annual ACTRIMS meeting, Baltimore, 10/19/2003
• Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis
  Avasarala JR et al, presented at the Proceedings of the VIII Annual ACTRIMS meeting, 10/1/2003
• Model of a new generation of tracheostomy and endotracheal tubes
  Avasarala JR, 38th Annual meeting of the American Laryngological Association, Florida, 4/23/1998
• Use of pulse oximetry for monitoring tracheostomy tube obstruction
  Avasarala JR, IVth Annual Japanese Conference on Pulse Oximetry, Tokyo, Japan, 10/1/1987
• Join now to see all